Binding sites of cytoplasmic effectors TRAF1, 2, and 3 on CD30 and other members of the TNF receptor superfamily

被引:88
作者
Boucher, LM
Marengere, LEM
Lu, Y
Thukral, S
Mak, TW
机构
[1] UNIV TORONTO, DEPT IMMUNOL, TORONTO, ON, CANADA
[2] AMGEN INST CANADA, TORONTO, ON, CANADA
[3] AMGEN INC, THOUSAND OAKS, CA 91320 USA
基金
英国医学研究理事会;
关键词
D O I
10.1006/bbrc.1997.6509
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CD30 is present on the surfaces of malignant cells from patients with Hodgkin's lymphoma, anaplastic large cell lymphoma, and other lymphomas. The yeast two hybrid genetic screen method was used to identify molecular effectors which mediate CD30 signalling events. Clones corresponding to genes coding for TRAF1, TRAF2 and TRAF3 molecules, postulated to be involved in signalling via the TNF and CD40 receptors, were isolated. In this report, we show that the CD30 intracellular tail contains two motifs that bind TRAFs. The more amino terminal motif, (558)PHYPEQET(565), binds TRAF2 and 3, while the more carboxyl terminal motif, (576)MLSVEEEG(583), binds TRAF1 and 2. We show that these amino acid motifs are conserved in TNFRp75 and CD40 and that sequences in these receptors homologous to TRAF-binding sequences found in CD30 can selectively bind the TRAFs in a predictable manner. (C) 1997 Academic Press.
引用
收藏
页码:592 / 600
页数:9
相关论文
共 44 条
  • [1] Aizawa S, 1997, J BIOL CHEM, V272, P2042
  • [2] Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice
    Amakawa, R
    Hakem, A
    Kundig, TM
    Matsuyama, T
    Simard, JJL
    Timms, E
    Wakeham, A
    Mittruecker, HW
    Griesser, H
    Takimoto, H
    Schmits, R
    Shahinian, A
    Ohashi, PS
    Penninger, JM
    Mak, TW
    [J]. CELL, 1996, 84 (04) : 551 - 562
  • [3] RETRACTED: Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation (Retracted article. See vol 94, pg 12732, 1997)
    Ansieau, S
    Scheffrahn, I
    Mosialos, G
    Brand, H
    Duyster, J
    Kaye, K
    Harada, J
    Dougall, B
    Hubinger, G
    Kieff, E
    Herrmann, F
    Leutz, A
    Gruss, HJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (24) : 14053 - 14058
  • [4] THE CD40 ANTIGEN AND ITS LIGAND
    BANCHEREAU, J
    BAZAN, F
    BLANCHARD, D
    BRIERE, F
    GALIZZI, JP
    VANKOOTEN, C
    LIU, YJ
    ROUSSET, F
    SAELAND, S
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 : 881 - 922
  • [5] BISWAS P, 1995, IMMUNITY, V2, P587
  • [6] Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death
    Boldin, MP
    Goncharov, TM
    Goltsev, YV
    Wallach, D
    [J]. CELL, 1996, 85 (06) : 803 - 815
  • [7] INVOLVEMENT OF CRAF1, A RELATIVE OF TRAF, IN CD40 SIGNALING
    CHENG, GH
    CLEARY, AM
    YE, ZS
    HONG, DI
    LEDERMAN, S
    BALTIMORE, D
    [J]. SCIENCE, 1995, 267 (5203) : 1494 - 1498
  • [8] DEBRUIN PC, 1995, LEUKEMIA, V9, P1620
  • [9] Devergne O, 1996, MOL CELL BIOL, V16, P7098
  • [10] LYMPHOTOXIN IS AN AUTOCRINE GROWTH-FACTOR FOR EPSTEIN-BARR-VIRUS INFECTED B-CELL LINES
    ESTROV, Z
    KURZROCK, R
    POCSIK, E
    PATHAK, S
    KANTARJIAN, HM
    ZIPF, TF
    HARRIS, D
    TALPAZ, M
    AGGARWAL, BB
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (03) : 763 - 774